Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
ID: 349478Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349478

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-238.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life," aimed at promoting research that explores the connection between social disconnection, including loneliness, and suicidal thoughts and behaviors among older adults. The initiative seeks applications for R01 grants to identify neurobiological and environmental mechanisms that increase suicide risk due to social isolation, as well as to develop interventions and service delivery models to enhance social connections in late life. This funding is particularly significant given the rising suicide rates among older adults and the need to improve health equity in mental health contexts. Interested applicants, including various educational institutions and community organizations, must submit their proposals by June 5, 2026, and can find additional information and guidelines at the NIH grants website or contact grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-238-Full-Announcement.html
    PAR-23-238.html
    The Department of Health and Human Services, through the National Institutes of Health, has issued a Notice of Funding Opportunity (NOFO) titled "Social Disconnection and Suicide Risk in Late Life." The purpose is to promote research linking social disconnection, including loneliness, to suicidal thoughts and behaviors in older adults. The focus is on identifying mechanisms whereby social disconnection increases suicide risk, while social integration might provide protection, encompassing neurobiological, behavioral, and environmental levels of analysis. The NOFO encourages applications for R01 grants, with a companion R21 opportunity for high-risk projects lacking preliminary data. Key dates include application submission deadlines beginning October 5, 2023, through June 5, 2026. Eligible applicants include various higher education institutions, nonprofits, and government entities. The funding aims to address the critical rise in suicide rates among older adults and improve health equity in the context of social connections and mental health. All applications must adhere to specific guidelines, and proposals will undergo thorough peer review based on significance, investigator expertise, innovation, research approach, and environment. This initiative highlights the urgent need for targeted research to better understand and address late-life suicide risks.
    Similar Opportunities
    Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)" aimed at supporting research on the relationship between social disconnection and suicide risk among older adults. This initiative seeks innovative projects that explore neurobiological, behavioral, and environmental mechanisms influencing social isolation and its impact on suicidal thoughts and behaviors, with an emphasis on promoting health equity and developing interventions to enhance social support. The grant provides a maximum funding amount of $275,000 over a two-year period, with applications due by September 7, 2026. Interested applicants can find more information and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)" aimed at supporting formative research and pilot testing of culturally sensitive interventions to address suicidal ideation and non-suicidal self-injury in low- and middle-income countries (LMICs). The initiative seeks to strengthen research capacity within the LMIC communities and requires applicants to conduct pilot studies that assess the feasibility, acceptability, and costs of proposed interventions. With an estimated total program funding of $2 million available for up to 8 awards, applicants can request direct costs of up to $225,000 per year for a maximum of three years. Interested parties must submit their applications by January 25, 2025, with the opportunity closing on October 24, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-160.html.
    Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Research Opportunities in Crisis Response Services for Suicide Prevention," aimed at supporting exploratory research into the effectiveness and implementation of crisis response services designed to prevent suicides. This initiative seeks to evaluate the impact of state and local policies on crisis service outcomes, focusing on real-world applications that consider various factors such as clinical presentations, geographic settings, cultural considerations, and health disparities. The total funding available is $2 million across fiscal years 2025-2026, with individual project budgets capped at $225,000 per year for a maximum of three years. Interested applicants can find more information and submission guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov. The application deadline is June 2, 2025.
    Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)" aimed at advancing research on crisis response services related to suicide prevention. This initiative seeks proposals that examine the impact of state and local policies on the implementation and outcomes of crisis response services, particularly in the context of the 988 rollout, while considering various demographic and psychosocial factors. The program emphasizes the importance of real-world research settings and encourages community collaborations to enhance the practical application of findings. Up to $2,000,000 is available for this initiative, with the intention of awarding approximately 3-5 grants annually over a potential project period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application window opening on September 1, 2024, and the close date set for June 2, 2025.
    Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings," aimed at evaluating the effectiveness of interventions that promote the safe storage of potentially lethal means, such as firearms and medications, for individuals at increased risk of suicide. This initiative, through the National Institute of Mental Health (NIMH), seeks applications for R34 Planning Grants to conduct pilot effectiveness research on lethal means safety strategies, which have shown promise in reducing suicide attempts but require further evidence in healthcare and community settings. The total funding available is $1.5 million, with up to six grants awarded, each with a maximum budget of $450,000 over three years. Interested applicants must submit their proposals by June 15, 2024, for an initial review in November 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)" aimed at advancing research on schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to explore the mechanisms, trajectories, and outcomes of these disorders, with a focus on identifying targets for prevention and treatment interventions, particularly emphasizing the inclusion of diverse research teams and individuals with lived experience. The funding is available through the R01 grant mechanism, with applications due by September 7, 2026, and interested applicants are encouraged to adhere strictly to the application guidelines and contribute data to the National Institute of Mental Health Data Archive. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-023.html.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life" (PAR-24-026), aimed at advancing research on the onset and progression of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to promote high-risk exploratory and developmental projects that investigate neurobiological, psychosocial, and environmental factors contributing to these disorders, with a particular emphasis on addressing health disparities among minority and aging populations. The program offers a maximum funding amount of $275,000 over two years, with applications due by November 16, 2023, for the initial cycle. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Healthcare for Older Adults from Populations that Experience Health Disparities" under the R01 Clinical Trial Optional grant program. This initiative aims to enhance the science and implementation of healthcare research focused on older adults from populations facing health disparities, specifically targeting improvements in screening, diagnostic, and clinical care guidelines, as well as fostering shared decision-making between clinicians and patients. The research is particularly significant for addressing the unique health challenges encountered by older adults from racial and ethnic minorities and underserved communities, emphasizing innovative care solutions that consider social determinants of health. Interested applicants can find more information and apply through the NIH Grants website, with the application opening on January 5, 2025, and a close date set for January 7, 2028. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders" (R61/R33 Clinical Trial Required). This initiative aims to support pilot research that develops and tests innovative psychosocial interventions targeting mental disorders in both adults and children, focusing on early-stage exploratory clinical trials to assess how these interventions engage biological, cognitive, or behavioral targets linked to mental health issues. Successful projects will receive funding for up to two years in the R61 phase for preliminary studies, with the potential for an additional three years in the R33 phase contingent upon meeting specified milestones. Interested applicants must adhere to strict guidelines regarding human subject protections and submit their applications through Grants.gov by the deadline of October 15, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for the Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). This initiative aims to support pilot research focused on innovative psychosocial intervention strategies for both adults and children, emphasizing the experimental therapeutic approach to address underlying mechanisms of mental disorders. The funding will facilitate exploratory clinical trials for up to three years, with no specific budget limits, provided they reflect actual project needs, and applications must demonstrate a strong scientific rationale and empirical support. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of October 15, 2024.